Compare Invitation Homes Inc. Common Stock (INVH) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invitation Homes Inc. Common Stock vs ResMed Inc. — how do they compare? Invitation Homes Inc. Common Stock trades at $26.86 (market cap $15.68B), while ResMed Inc. trades at $241.15 (market cap $33.09B). The key difference: ResMed Inc. is far larger — about 2.1× Invitation Homes Inc. Common Stock's market cap, and Invitation Homes Inc. Common Stock pays the higher dividend (4.52%). Which is the better fit depends on your goals — on Pluang, investors hold Invitation Homes Inc. Common Stock for 0 Days and ResMed Inc. for 51 Days on average.
| INVH | RMD | |
|---|---|---|
Market Cap | $15.68B | $33.09B |
Volume | 3,619,685 | 1,019,685 |
Sector | Real Estate | Health |
52-Week High | $30.59 | $275.96 |
52-Week Low | $24.39 | $182.82 |
Typical Hold Time | 0 Days | 51 Days |
Enterprise Value | $24.13B | $32.45B |
Dividend Yield | 4.52% | 1.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INVH trades at $26.59, down 0.41% on the day, with neutral technical signals and strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected soon. Revenue growth from $2.73B in 2025 to $2.9B projected for 2026 supports a solid profit margin expansion to 23.13%. Analyst consensus remains bullish with a $31.67 price target, representing 19% upside potential from current levels.
The investment case centers on INVH's consistent earnings outperformance and robust single-family rental demand, though rising interest rates pose headwinds. With 56% of analysts recommending Buy and institutional accumulation continuing, the stock offers value at current levels despite technical consolidation. Key risks include interest rate sensitivity and regulatory changes affecting institutional homebuying.
ResMed (RMD) trades at $240.56, up 2.35% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 2025 revenue of $5.15B, net income of $1.40B (27.21% margin), and consistent earnings beats. Recent news highlights management's participation in healthcare conferences and upcoming Q1 2027 earnings on October 29, 2026.
Outlook remains positive with 12-14% EPS growth guidance and analyst consensus target of $243.56. Key risks include competitive pressures and ongoing legal investigations. Institutional ownership trends show continued accumulation by major funds, supporting the bullish sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Invitation Homes Inc. Common Stock
Invitation Homes Inc. is a real estate investment trust that acquires, renovates, and leases single-family rental homes across roughly 19 US markets concentrated in Western and Southeastern US. It manages its portfolio through a pod-based local operating model supported by a maintenance technology platform.
Read more on INVH →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
